ArticleInternational journal of biological sciences2021

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.

Yewei Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.